These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12650632)

  • 1. Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions.
    van Puijenbroek E; Diemont W; van Grootheest K
    Drug Saf; 2003; 26(5):293-301. PubMed ID: 12650632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of measures of disproportionality in pharmacovigilance: three Dutch examples.
    Egberts AC; Meyboom RH; van Puijenbroek EP
    Drug Saf; 2002; 25(6):453-8. PubMed ID: 12071783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of time-to-onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands.
    Scholl JH; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1361-1367. PubMed ID: 27686554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions in response to drug safety signals arising from a spontaneous reporting system: Retrospective study in The Netherlands.
    Rolfes L; Kolfschoten J; van Hunsel F; Kooijman M; van Puijenbroek E
    Int J Risk Saf Med; 2016 Aug; 28(2):115-23. PubMed ID: 27567768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.
    van Puijenbroek EP; Bate A; Leufkens HG; Lindquist M; Orre R; Egberts AC
    Pharmacoepidemiol Drug Saf; 2002; 11(1):3-10. PubMed ID: 11998548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.
    van Hunsel F; de Waal S; Härmark L
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):977-983. PubMed ID: 28524293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
    Hauben M; Horn S; Reich L
    Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs.
    van Puijenbroek EP; Egberts AC; Heerdink ER; Leufkens HG
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):733-8. PubMed ID: 11214785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal detection: historical background.
    Egberts TC
    Drug Saf; 2007; 30(7):607-9. PubMed ID: 17604412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing impairment associated with oral terbinafine use: a case series and case/non-case analysis in the Netherlands Pharmacovigilance Centre Lareb database and VigiBase™.
    Scholl JH; van Puijenbroek EP
    Drug Saf; 2012 Aug; 35(8):685-91. PubMed ID: 22762134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
    Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
    J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reported adverse drug reactions and their determinants in Dutch children outside the hospital.
    Schirm E; Tobi H; van Puijenbroek EP; Monster-Simons MH; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):159-65. PubMed ID: 15072115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
    Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
    Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An innovative method to strengthen evidence for potential drug safety signals using Electronic Health Records.
    Abedian Kalkhoran H; Zwaveling J; van Hunsel F; Kant A
    J Med Syst; 2024 May; 48(1):51. PubMed ID: 38753223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.
    van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH
    Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study.
    van Hunsel F; Talsma A; van Puijenbroek E; de Jong-van den Berg L; van Grootheest K
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):286-91. PubMed ID: 21351310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of signal selection in a spontaneous reporting system for adverse drug reactions.
    van Puijenbroek EP; van Grootheest K; Diemont WL; Leufkens HG; Egberts AC
    Br J Clin Pharmacol; 2001 Nov; 52(5):579-86. PubMed ID: 11736867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.